Prot# K847-08-4003: A Phase 4, Multicenter, Open-Label, Observational Study Assessing the Impact of Exposure to THROMBIN-JMI (Thrombin, Topical U.S.P. [Bovine Origin]) on Coagulation Parameters

Project: Research project

Project Details

StatusFinished
Effective start/end date4/3/09 → 4/3/12

Funding

  • King Pharmaceuticals Research and Development, Inc. (K847-08-4003)